DNM1L and diabetic kidney disease: Drp1-specific knockdown in podocytes or pharmacologic inhibition of Drp1 by mitochondrial division inhibitor 1 (Mdivi-1) in diabetic mice confers protection against DKD with decreased albuminuria and improved morphology compared to diabetic control mice (Ayanga et al., 2016).